TCT 205: A Proposed Protocol to Reduce Contrast Volume in the Endovascular Laboratory: Results of the SAVE CONTRAST Study

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:

• Grant Support/Research Contract - Boston Scientific Corporation; Bard Medical; Philips; Angiodynamics
• Consultant Fee/Honoraria/Speaker's Bureau - Boston Scientific Corporation; Angiodynamics